Global Preventive Vaccines Market is valued at USD 43.52 Billion in 2021 and expected to reach USD 62.06 Billion by 2028 with a CAGR of 13.1% over the forecast period.
Global Preventive Vaccines Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- The increasing burden of infectious diseases, rising approvals for preventive vaccines and growing government funding for vaccine development are major factors anticipated to drive the growth of the Global Preventive Vaccines Market.
Get Sample Report: https://brandessenceresearch.com/requestSample/PostId/1944
Scope of Global Preventive Vaccines Market Report:-
The vaccines used for prevention of any type infectious disease are called preventive vaccines. Also preventive vaccines are used for reducing the risk of oncoviruses or viral infections which are responsible for the development of several cancers. Head, neck, and cervical cancer is caused by human papillomavirus, or HPV, whereas liver cancer can be caused by hepatitis B virus or HBV. However, these vaccines were not effective against cancer that was already developed by oncoviruses. Numerous vaccines have been developed that can prevent HBV and HPV infection and, as a result, protect against the formation of HBV- and HPV-related cancers. U.S. Food and Drug Administration (FDA) had these preventive vaccines.
The Covid -19 pandemic has shown a positive impact on the growth of the global preventive vaccines market. The Covid-19 pandemic had shown a significant impact on healthcare industry. The focus and research and development activities regarding the preventive vaccines has been increased during pandemic. The increased evolving healthcare spending, evolving vaccine technologies and the demand of preventive vaccines has been increased which positively impacted the global preventive vaccines market growth during pandemic.
Global Preventive Vaccines Market Segmentation:-
The global preventive vaccines market is segmented on the basis of type, disease, and region & country level. Based upon type, the global preventive vaccines market is segmented into live/attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vector vaccines and other vaccines. On the basis of disease, the market is segmented into pneumococcal disease, poliovirus, hepatitis, influenza, measles, mumps, and rubella (MMR), Varicella, human Papilloma virus, COVID-19 and other diseases.
- Live/Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Conjugate Vaccines
- Recombinant Vector Vaccines
- Other Vaccines
- Pneumococcal Disease
- Measles, Mumps, and Rubella (MMR)
- Human Papilloma Virus
- Other Diseases
Key Players of Global Preventive Vaccines Market:-
Some of the key players for the global preventive vaccines market are
- Johnson and Johnson
- CSL Ltd
- Serum Institute of India
News: Cleveland Clinic Launched First-of-its-Kind Preventive Breast Cancer Vaccine Study
On October 26th, 2021; Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. This phase I trial is designed to determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer and to characterize and optimize the body’s immune response. The U.S. Food and Drug Administration recently approved an investigational new drug application for the vaccine, which permits Cleveland Clinic and partner Anixa Biosciences, Inc. to start the study.
India Launched 9-Valent HPV Vaccine
On September 30th, 2021; MSD Pharmaceuticals Mumbai announced launch of the Gardasil 9 Human Papillomavirus (HPV) vaccine to help reduce the HPV-related cancer burden in India. Cancers caused by HPV types contained in the vaccine among girls and women aged 9-26 years and boys aged between 9-15 years can be reduced by Gardasil 9 is a 9-valent HPV vaccine. Moreover, vaginal cancer, vulvar cancer, and cervical cancer can be reduced with help of Gardasil 9. Boys who are suffering from anal intraepithelial neoplasia, anal cancer and precancerous or dysplastic lesions the Gardasil 9 vaccine is recommended.
Increasing Burden of Infectious Diseases, Rising Approvals for Preventive Vaccines and Growing Government Funding for Vaccine Development are Driving the Market Growth
North America is expected to dominate the global preventive vaccines market due to the increasing adoption of preventive vaccines, highly developed healthcare infrastructure and presence of major key players along with R&D laboratories in this region. The adoption of preventive vaccines for life-threating diseases is increasing the market growth of preventive vaccines.
Asia-Pacific is expected to witness a significant growth in global preventive vaccines market due to increasing research in the emerging countries, rising prevalence of infectious diseases and growing government initiatives to increase the awareness regarding the vaccines in this region. The ongoing research in preventive vaccines in this region is supplementing the growth of the preventive vaccines in this region.
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.